Interview 23 Aug 2021Behind the Scenes at Novo Seeds: Building Startups from the Ground up Søren Møller, Managing Investment Director at Novo Seeds, discusses how the firm’s investment strategy has changed over time to support… August 23, 2021 - 9 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
Interview 11 Dec 2019Collaboration Between Founders and Investors Primes Biotech Startups for Success How can entrepreneurs work with investors to maximize the chances of their company succeeding? Venture capital partner Nanna Lüneborg and… December 11, 2019 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 15 Mar 2018French VC Raises the Biggest Green Biotech Fund in the World Update (15/03/2018): Sofinnova Partners has closed its fund Industrial Biotech I at €125M, making it the largest fund dedicated to… March 15, 2018 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 31 May 2017Swiss Biotech raises €10M to Target Elusive Protein Interactions in Cancer Inthera Bioscience has raised €9.6M in Series A to complete preclinical phase of its lead cancer program and expand its pipeline. Inthera… May 31, 2017 - 1 minutemin - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Startup Scout 13 Jan 2017The Good, the Bad and the Cancer-Fighting Macrophage We decided to stick around England this week and made a short trip from London to visit the young biotech… January 13, 2017 - 1 minutemin - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 18 Dec 2015Biotech of the week: Forendo Pharma, Finland hasn’t only got Santa Claus! This week we leave Copenhagen but stay in Scandinavia, pass through Norway and arrive at this week's destination, Finland. This… December 18, 2015 - 2 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
News and Trends 17 Dec 2015The Assault on Solid Tumors: How ‘Blinding’ Cancer is an Attractive Therapeutic Approach The Dutch Oncology VC Specialist Aglaia has invested €3.4M in the Swiss Start-Up Inthera Bioscience for their Small molecule platform… December 17, 2015 - 3 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email